Welcome to Roivant
Eyes

Reinventing the discovery, development, and commercialization of new medicines

About Us

We develop transformative medicines and technologies by building agile, focused companies called Vants.

Our companies

Our model aligns incentives to drive fast, high-quality execution and rigorous capital allocation.

We employ technology across discovery, development, and commercialization.

 

Immunovant

Immunovant

Advancing potentially transformative therapies for autoimmune diseases

Vtama tube

Dermavant

Fostering unprecedented change and unparalleled impact in immuno-dermatology

priovant

Priovant

Developing targeted therapies for patients with severe autoimmune disease

video section decoration

Roivant Overview - JP Morgan Healthcare Conference 2024

For Investors
For Investors

Learn more about our work

Sign up for our latest announcements and upcoming presentations

Pipeline
Pipeline

Advancing medicines that matter

View our broad and differentiated pipeline of investigational drugs.